MoneyWorks4Me

The sales moved up 26.71% to Rs. 1424.93 millions for the March 2024 quarter as compared to Rs. 1124.60 millions during the year-ago period.An average growth of 48.03% was recorded for the quarter ended March 2024 to Rs. 185.97  millions from Rs. 125.63 millions.OP of the company witnessed a marginal growth to 254.02 millions from 205.43 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1424.93 1124.60 26.71 5805.50 5103.09 13.76 5805.50 5103.09 13.76
Other Income 70.19 39.46 77.88 344.22 224.84 53.10 344.22 224.84 53.10
PBIDT 254.02 205.43 23.65 1343.30 1116.50 20.31 1343.30 1116.50 20.31
Interest 4.99 11.48 -56.53 14.63 20.29 -27.90 14.63 20.29 -27.90
PBDT 249.03 193.95 28.40 1328.67 1096.21 21.21 1328.67 1096.21 21.21
Depreciation 26.86 24.13 11.31 106.25 91.66 15.92 106.25 91.66 15.92
PBT 222.17 169.82 30.83 1222.42 1004.55 21.69 1222.42 1004.55 21.69
TAX 36.20 44.19 -18.08 289.38 275.56 5.02 289.38 275.56 5.02
Deferred Tax -4.93 10.11 -148.76 34.95 15.86 120.37 34.95 15.86 120.37
PAT 185.97 125.63 48.03 933.04 728.99 27.99 933.04 728.99 27.99
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 17.83 18.27 -2.41 23.14 21.88 5.76 23.14 21.88 5.76
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..